Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Estratégias na esquizofrenia - Aderente à adesão	Gäst
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/en/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Dr. Mattingly discute abordagens durante a pandemia	Gäst
Newsletter opened	Thu, 08/13/2020 - 17:39	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Gäst
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Gäst
Newsletter opened	Thu, 08/13/2020 - 13:50	Opened		Gäst
Email verified	Wed, 10/12/2022 - 13:23	Email verified		Gäst
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Greece newsletter		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Gäst

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Estratégias na esquizofrenia - Aderente à adesão	Gäst
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/en/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Dr. Mattingly discute abordagens durante a pandemia	Gäst
Newsletter opened	Thu, 08/13/2020 - 17:39	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Gäst
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Gäst
Newsletter opened	Thu, 08/13/2020 - 13:50	Opened		Gäst
Email verified	Wed, 10/12/2022 - 13:23	Email verified		Gäst
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Greece newsletter		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Gäst

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER